Back to Results
First PageMeta Content
Apoptosis / Programmed cell death / Proteins / Oncology / Survivin / Telomerase / Carcinogenesis / P53 / Bcl-2-associated X protein / Biology / Medicine / Cell biology


WRAP53 promotes cancer cell survival and is a potential target for cancer therapy
Add to Reading List

Document Date: 2011-01-13 05:57:04


Open Document

File Size: 757,00 KB

Share Result on Facebook

City

Bradford / Stockholm / Heidelberg / Paisley / Anchorage / Santa Cruz / Newcastle / Sollentuna / Calbiochem / Paisly / Sundbyberg / Leuvenheim / Palo Alto / Lund / Cologne / Toulouse / /

Company

Vector Laboratories Ltd. / Sigma-Aldrich / Qiagen / Bethyl Laboratories Inc. / GE Healthcare / BD Biosciences / Wiman KG / Bio-Rad Laboratories AB / Novacastra Laboratories Ltd. / Matera AG / Innovagen AB / Quest software / Invitrogen Corporation / Pearson / Integro B.V. / Creative Commons / Carl Zeiss AB / Socialstyrelsen’s Funds / Macmillan Publishers Limited / /

Country

Netherlands / France / United Kingdom / Germany / Sverige / Sweden / United States / /

Currency

pence / /

/

Event

FDA Phase / /

Facility

Linko¨ping University / Karolinska Hospital / SMN complex / /

IndustryTerm

cancer therapy / histone mRNA processing / machinery / epitope retrieval solution / treatment of human cancers / spinal muscular atrophy gene product / oil immersion lenses / /

MedicalCondition

Cancer The WRAP53 / human tumor / squamous-cell carcinoma / primary HNSCC tumors / breast cancer / embryonic kidney cancer / Tumor / adenoma / cancer / tumors / carcinogenesis / invasive epithelial ovarian cancer / human cancer / head and neck carcinogenesis / oral squamous cell carcinoma / DF / head and neck carcinoma / Fresh tumor / patient tumor / several well-known cancer / human cancers / J Cancer / colon cancer / sporadic primary hyperparathyroidism / head and neck cancer / primary tumors / spinal muscular atrophy / Disease / larger tumor / aggressive disease / p53 tumor / lung cancer / adenocarcinoma cells / primary human cancers / HNSCC tumor / Mol Cancer / Increased epidermal tumors / /

MedicalTreatment

Radiotherapy / surgery / cancer therapy / antibiotics / anticancer therapy / /

NaturalFeature

Berciano MT / /

Organization

Karolinska Hospital / HUGO Gene Nomenclature Committee / Department of Oncology-Pathology / Department of Clinical and Experimental Medicine / Johns Hopkins Oncology Center / A˚ke Olsson’s Fund / Mary Beve’s Fund / International Union against Cancer / Swedish Cancer Society / Radiumhemmets Fund / Linko¨ping University / National Institute of Health / Cajal / A˚ke Wiberg’s Fund / Swedish Childhood Cancer Society / Department of Defense / /

Person

Alexa Fluor / Gene Nomenclature / Bertrand Joseph / Reza-Albarran A et al. Differential / Inoue M. Understanding / Joe A. Oncogene / /

/

Position

RT / Walker MP / Tian L / WB / Sweden *Corresponding author / Terns MP / cold WB / recently established head / artificial reporter / Marshall / /

Product

Fungizone / Sigma / Flag / WRAP53 / penicillin / Cell Quest software / amphotericin B / Cell Quest / Mg2 / /

ProvinceOrState

Peterborough / Pendle / /

PublishedMedium

PLoS Biology / PLoS One / /

Technology

siRNA / stem cells / apoptosis / DNA Chip / gene expression / treating cancer / Bioinformatics / antibodies / artificial intelligence / /

URL

http /

SocialTag